Gramicidin
Antibiotics
- Drug class
- Antibiotics
- Availability
- See label
- Routes
- Ophthalmic, Topical, Nasal
- Markets covered
- 2
- Products on record
- 11
Overview
Gramicidin is an active pharmaceutical ingredient in the Antibiotics group (R02AB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 8 | November 8, 2025 |
| GB United Kingdom | MHRA | 3 | January 16, 2026 |
CACanada· Health Canada
8 products
8 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
GBUnited Kingdom· MHRA
3 products
3 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]Health Canada (DPD) · 02224860 · revised March 22, 2025
- [2]MHRA (UK) · PLPI151841915 · revised May 23, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.